Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-09-004230
Filing Date
2009-05-12
Accepted
2009-05-12 16:31:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. c0628618sv1za.htm S-1/A 2082194
2 EX-10.6.2 c0628618exv10w6w2.htm EX-10.6.2 10217
3 EX-10.9.3 c0628618exv10w9w3.htm EX-10.9.3 6426
4 EX-23.1 c0628618exv23w1.htm EX-23.1 2688
5 GRAPHIC c0628618c0628602.gif GRAPHIC 3768
6 GRAPHIC c0628618c0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-09-004230.txt   2108842
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 09819215
SIC: 2834 Pharmaceutical Preparations